Lucilia Saraiva

LAQV/REQUIMTE, University of Porto

Research Area

Biography

Lucilia Saraiva has not added Biography.
If you are Lucilia Saraiva and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 16	2019

Other Publications

Article	Year
New insights into cancer-related proteins provided by the yeast model. The FEBS journal\| PubMed ID: 22239976	2012
New therapeutic strategies for cancer and neurodegeneration emerging from yeast cell-based systems. Current pharmaceutical design\| PubMed ID: 22650181	2012
Endocytosis inhibition during H2O2-induced apoptosis in yeast. FEMS yeast research\| PubMed ID: 22741558	2012
Interference of aging media on the assessment of yeast chronological life span by propidium iodide staining. Folia microbiologica\| PubMed ID: 22828896	2013
Contribution of yeast and plant research for improving human health. Journal of biomedicine & biotechnology\| PubMed ID: 22851885	2012
Contribution of yeast models to neurodegeneration research. Journal of biomedicine & biotechnology\| PubMed ID: 22910375	2012
SNaPaer: a practical single nucleotide polymorphism multiplex assay for genotyping of Pseudomonas aeruginosa. PloS one\| PubMed ID: 23776608	2013
Potential small-molecule activators of caspase-7 identified using yeast-based caspase-3 and -7 screening assays. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences\| PubMed ID: 24398107	2014
LRRK2, but not pathogenic mutants, protects against H2O2 stress depending on mitochondrial function and endocytosis in a yeast model. Biochimica et biophysica acta\| PubMed ID: 24576675	2014
Microglia P2Y₆ receptors mediate nitric oxide release and astrocyte apoptosis. Journal of neuroinflammation\| PubMed ID: 25178395	2014
Studying p53 family proteins in yeast: induction of autophagic cell death and modulation by interactors and small molecules. Experimental cell research\| PubMed ID: 25265062	2015
Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences\| PubMed ID: 25312347	2015
A yeast model of the Parkinson's disease-associated protein Parkin. Experimental cell research\| PubMed ID: 25728007	2015
A tryptophanol-derived oxazolopiperidone lactam is cytotoxic against tumors via inhibition of p53 interaction with murine double minute proteins. Pharmacological research\| PubMed ID: 25814188	2015
Chronological aging in conidia of pathogenic Aspergillus: Comparison between species. Journal of microbiological methods\| PubMed ID: 26341609	2015
Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction. Life sciences\| PubMed ID: 26475964	2015
p53 family interactions and yeast: together in anticancer therapy. Drug discovery today\| PubMed ID: 26891980	2016
Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction. Medicinal research reviews\| PubMed ID: 27302609	2016
Discovery of a small-molecule protein kinase Cδ-selective activator with promising application in colon cancer therapy. Cell death & disease\| PubMed ID: 29348560	2018
p53 and glucose metabolism: an orchestra to be directed in cancer therapy. Pharmacological research\| PubMed ID: 29580896	2018
The Crystal Structure of the R280K Mutant of Human p53 Explains the Loss of DNA Binding. International journal of molecular sciences\| PubMed ID: 29652801	2018
Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity. European journal of medicinal chemistry\| PubMed ID: 30041135	2018
Improving anticancer activity towards colon cancer cells with a new p53-activating agent. British journal of pharmacology\| PubMed ID: 30076608	2018
New Alkoxy Flavone Derivatives Targeting Caspases: Synthesis and Antitumor Activity Evaluation. Molecules (Basel, Switzerland)\| PubMed ID: 30602686	2018
New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma. Cancer letters\| PubMed ID: 30664963	2019
Comparison Study of Different Extracts of , and the Rare (Lamiaceae): Chemical Characterization, Antioxidant, Antimicrobial and Cytotoxic Activities. Biomolecules\| PubMed ID: 31072074	2019
Synthesis, Biological Evaluation, and In Silico Studies of Novel Aminated Xanthones as Potential p53-Activating Agents. Molecules (Basel, Switzerland)\| PubMed ID: 31121972	2019